AHA: Apixaban Beneficial for Patients With Subclinical A-Fib

TUESDAY, Nov. 14, 2023 -- Apixaban results in a lower risk for stroke or systemic embolism than aspirin for patients with subclinical atrial fibrillation, according to a study published online Nov. 12 in the New England Journal of Medicine to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news